{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:20:16Z","timestamp":1782836416440,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s11033-020-05378-7","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T07:05:07Z","timestamp":1584342307000},"page":"2763-2769","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7582-6307","authenticated-orcid":false,"given":"P.","family":"Riedlova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Janoutova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hermanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"key":"5378_CR1","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/annonc\/mdv022","volume":"26","author":"S Shiovitz","year":"2015","unstructured":"Shiovitz S, Korde LA (2015) Genetics of breast cancer: a topic in evolution. Ann Oncol 26:1291\u20131299. https:\/\/doi.org\/10.1093\/annonc\/mdv022","journal-title":"Ann Oncol"},{"issue":"1","key":"5378_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2014.10.008","volume":"41","author":"P Economopoulou","year":"2015","unstructured":"Economopoulou P, Dimiridias G, Psyrri A (2015) Beyond BRCA: New hereditary breast cancer susceptibility genes. Cancer Treat Rev 41(1):1\u20138. https:\/\/doi.org\/10.1016\/j.ctrv.2014.10.008","journal-title":"Cancer Treat Rev"},{"key":"5378_CR3","unstructured":"Svod (2005). Accessed 17 September 2019. ISSN 1802\u20138861. https:\/\/www.svod.cz\/"},{"key":"5378_CR4","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.7314\/apjcp.2015.16.7.2857","volume":"16","author":"Y Kim","year":"2015","unstructured":"Kim Y, Yoo KY, Goodman MT (2015) Differences in Incidence, Mortality and Survival of Breast Cancer by Regions and Countries in Asia and Contributing Factors. Asian Pac J Cancer Prev 16:2857\u20132870. https:\/\/doi.org\/10.7314\/apjcp.2015.16.7.2857","journal-title":"Asian Pac J Cancer Prev"},{"key":"5378_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/sajc.sajc_157_16","volume":"6","author":"P Thakur","year":"2017","unstructured":"Thakur P, Seam RK, Gupta MK, Gupta M, Sharma M et al (2017) Breast cancer risk factor evaluation in a Western Himalayan state: a case\u2013control study and comparison with the Western World. South Asian Journal of Cancer 6:106\u2013109. https:\/\/doi.org\/10.4103\/sajc.sajc_157_16","journal-title":"South Asian Journal of Cancer"},{"key":"5378_CR6","first-page":"1","volume":"43","author":"M Zenhendel","year":"2018","unstructured":"Zenhendel M, Niakan B, Keshtkar A, Rafiei E, Salamat F (2018) Subtypes of benign breast disease as a risk factor for breast cancer: a systematic review and meta-analysis protocol. Iran J Med Sci 43:1\u20138","journal-title":"Iran J Med Sci"},{"key":"5378_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4236\/ojog.2015.52011","volume":"05","author":"FZ Laamiri","year":"2015","unstructured":"Laamiri FZ, Bouayad A, Hasswane N, Ahid S, Mrabet M et al (2015) Risk factors for breast cancer of different age groups: moroccan data. Open J Obstet Gynecol 05:79\u201387. https:\/\/doi.org\/10.4236\/ojog.2015.52011","journal-title":"Open J Obstet Gynecol"},{"key":"5378_CR8","first-page":"151","volume":"11","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Salehiniya H (2019) Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer 11:151\u2013164","journal-title":"Breast Cancer"},{"key":"5378_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.22038\/RCM.2017.9258","volume":"4","author":"FH Shandiz","year":"2017","unstructured":"Shandiz FH, Talasaz ZH (2017) The relationship between breast cancer and air pollution: review article. Review Clinical Medicine 4:136\u2013139. https:\/\/doi.org\/10.22038\/RCM.2017.9258","journal-title":"Review Clinical Medicine"},{"key":"5378_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2407-8-140","volume":"8","author":"E Machackova","year":"2008","unstructured":"Machackova E, Foretova L, Lukesova M, Vasickova P, Navratilova M et al (2008) Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and\/or ovarian cancer. BMC Cancer 8:140. https:\/\/doi.org\/10.1186\/1471-2407-8-140","journal-title":"BMC Cancer"},{"key":"5378_CR11","first-page":"55","volume":"19","author":"M Lukesova","year":"2006","unstructured":"Lukesova M, Machackova E, Vasickova P, Navratilova M, Pavlu H et al (2006) V\u00fdsledky testov\u00e1n\u00ed BRCA1 a BRCA2 gen\u016f Masaryova onkologick\u00e9ho \u00fastavu. Klin Onkol 19:55\u201357","journal-title":"Klin Onkol"},{"issue":"10","key":"5378_CR12","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","volume":"123","author":"SS Buys","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A, Patel G, Kidd J et al (2017) A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer 123(10):1721\u20131730. https:\/\/doi.org\/10.1002\/cncr.30498","journal-title":"Cancer"},{"issue":"5","key":"5378_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jmoldx.2015.04.009","volume":"17","author":"SE Lincoln","year":"2015","unstructured":"Lincoln SE, Kobayashi Y, Anderson MJ, Yang S, Desmond AJ et al (2015) A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients. J Mol Diagn 17(5):533\u2013544. https:\/\/doi.org\/10.1016\/j.jmoldx.2015.04.009","journal-title":"J Mol Diagn"},{"issue":"13","key":"5378_CR14","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","volume":"34","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J, Allen BA, Singh N et al (2016) Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. J Clin Oncol 34(13):1460\u20131468. https:\/\/doi.org\/10.1200\/JCO.2015.65.0747","journal-title":"J Clin Oncol"},{"issue":"5","key":"5378_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/djv036","volume":"107","author":"N Mavaddat","year":"2015","unstructured":"Mavaddat N, Pharoah PDP, Michailidou K, Tyrer J, Brook MN et al (2015) Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants. JNCI: Journal of the National Cancer Institute 107(5):1\u201315. https:\/\/doi.org\/10.1093\/jnci\/djv036","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"5378_CR16","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.14735\/amko2016S31","volume":"29","author":"M Janatova","year":"2016","unstructured":"Janatova M, Borecka M, Soukupova J, Kleiblova P, Stribrna J et al (2016) PALB2 as another candidate gene for genetic testing in patients with hereditary breast cancer in Czech Republic. Klinick\u00e1 onkologie 29:S31\u2013S34. https:\/\/doi.org\/10.14735\/amko2016S31","journal-title":"Klinick\u00e1 onkologie"},{"issue":"6","key":"5378_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.breast.2014.10.005","volume":"23","author":"E Molina-Montes","year":"2014","unstructured":"Molina-Montes E, Perez-Nevot B, Pollan M, Sanchez-Cantalejo E, Espin J et al (2014) Cumulative risk of second primary contralateral breast cancer in BRCA1\/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis. The Breast 23(6):721\u2013742. https:\/\/doi.org\/10.1016\/j.breast.2014.10.005","journal-title":"The Breast"},{"issue":"S1","key":"5378_CR18","first-page":"S2","volume":"5","author":"HA Assi","year":"2013","unstructured":"Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH et al (2013) Epidemiology and prognosis of breast cancer in young women. Thorac Dis 5(S1):S2\u2013S8","journal-title":"Thorac Dis"},{"key":"5378_CR19","unstructured":"Genetika \u2013 Biologie (2010). Accessed 17 September 2019. https:\/\/www.genetika-biologie.cz\/hereditarni-nadorove-syndromy"},{"key":"5378_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1158\/1055-9965.EPI-03-0196","volume":"13","author":"N Suter","year":"2004","unstructured":"Suter N, Ray RM, Hu JW, Li MG, Porter P et al (2004) BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer Epidemiol Biomarkers Prev 13:181\u2013189","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5378_CR21","first-page":"247","volume":"4","author":"X Yang","year":"2015","unstructured":"Yang X, Hu Z, Wu J, Liu G, Shen Z et al (2015) Breast cancer in BRCA1 or BRCA2 mutation carriersin Chinese Han population. China oncol 4:247\u2013252","journal-title":"China oncol"},{"key":"5378_CR22","first-page":"441","volume":"156","author":"L Yao","year":"2016","unstructured":"Yao L, Sun J, Zhang J, He Y, Ouyang T et al (2016) Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations. Springer 156:441\u2013445","journal-title":"Springer"},{"key":"5378_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/513317","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wang X, Song B, Shao K, Li G et al (2019) Gene panel sequencing in a Chinese high-risk breast cancer cohort. bioRxiV. https:\/\/doi.org\/10.1101\/513317","journal-title":"bioRxiV"},{"key":"5378_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"11","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D, Ellis S, Platte R et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. JNCI 11:812\u2013822. https:\/\/doi.org\/10.1093\/jnci\/djt095","journal-title":"JNCI"},{"key":"5378_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2013-101974","author":"RM Brohet","year":"2013","unstructured":"Brohet RM, Velthuizen ME, Hogervorst FBL, Meijers-Heijboer HEJ, Seynaeve C et al (2013) Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet. https:\/\/doi.org\/10.1136\/jmedgenet-2013-101974","journal-title":"J Med Genet"},{"key":"5378_CR26","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"23","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM et al (2017) Risks of breast, ovarian and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 23:2402\u20132413. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"key":"5378_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10555-010-9218-3","volume":"29","author":"A Tinelli","year":"2010","unstructured":"Tinelli A, Malvasi A, Leo G, Vergara D, Pisano M et al (2010) Hereditary ovarian cancers: from BRCA mutations to clinical management A modern appraisal. Cancer Metastasis Rev 29:339\u2013350","journal-title":"Cancer Metastasis Rev"},{"key":"5378_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.critrevonc.2008.06.003","volume":"69","author":"A Russo","year":"2009","unstructured":"Russo A, Cal\u00f2 V, Bruno L, Rizzo S, Bazan V, Di Fede G (2009) Hereditary ovarian cancer. Crit Rev Oncol Hematol 69:28\u201344","journal-title":"Crit Rev Oncol Hematol"},{"key":"5378_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10549-017-4642-5","volume":"168","author":"M Jakimovska","year":"2018","unstructured":"Jakimovska M, Kostovska IM, Popovska-Jankovic K, Kubelka-Sabit K, Karadjozov M et al (2018) BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia. Breast Cancer Res Treat 168:745\u2013753. https:\/\/doi.org\/10.1007\/s10549-017-4642-5","journal-title":"Breast Cancer Res Treat"},{"key":"5378_CR30","first-page":"659","volume":"152","author":"B Park","year":"2015","unstructured":"Park B, Dowty JG, Ahn CH, Win AK, Kim SW et al (2015) Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2. Springer 152:659\u2013665","journal-title":"Springer"},{"key":"5378_CR31","doi-asserted-by":"publisher","first-page":"e677","DOI":"10.1002\/mgg3.677","volume":"7","author":"X Wang","year":"2019","unstructured":"Wang X, Liu H, Maimaitiaili A, Zhao G, Li S et al (2019) Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high-risk breast cancer. Mol Genet Genomic Med 7:e677. https:\/\/doi.org\/10.1002\/mgg3.677","journal-title":"Mol Genet Genomic Med"},{"key":"5378_CR32","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.1038\/s41598-019-46707-6","volume":"9","author":"FH Hung","year":"2019","unstructured":"Hung FH, Wang YA, Jian JW, Peng HP, Hsieh LL et al (2019) (2019) Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan. Scientific Reports 9:10229. https:\/\/doi.org\/10.1038\/s41598-019-46707-6","journal-title":"Scientific Reports"},{"issue":"5","key":"5378_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/(SICI)1098-1004(200005)15:5%3c480::AID-HUMU13%3e3.0.CO;2-G","volume":"15","author":"M van Der Looij","year":"2000","unstructured":"van Der Looij M, Wysocka B, Brozek I, Jassem J, Limon J et al (2000) Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and\/or ovarian cancer families from North-Eastern Poland. Hum Mutat 15(5):480\u2013481. https:\/\/doi.org\/10.1002\/(SICI)1098-1004(200005)15:5%3c480:AID-HUMU13%3e3.0.CO;2-G","journal-title":"Hum Mutat"},{"issue":"4","key":"5378_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10689-017-9978-9","volume":"16","author":"I Gorodetska","year":"2017","unstructured":"Gorodetska I, Serga S, Lahuta T, Ostapchenko L, Demydov S et al (5382insC) Prevalence of two BRCA1 mutations, 5382insC and 300T %3e G, in ovarian cancer patients from Ukraine. Fam Cancer 16(4):471\u2013476. https:\/\/doi.org\/10.1007\/s10689-017-9978-9","journal-title":"Fam Cancer"},{"key":"5378_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/194293","volume":"2015","author":"A LaraquiI","year":"2015","unstructured":"LaraquiI A, Uhrhammer N, El Rhaffouili H, Sekhsokh Y, Lahlou-Amineet I et al (2015) BRCA genetic screening in Middle Eastern and North African: Mutational Spectrum and Founder BRCA1 Mutation (c.798_799delTT) in North African. Dis Markers 2015:1\u20138. https:\/\/doi.org\/10.1155\/2015\/194293","journal-title":"Dis Markers"},{"key":"5378_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1590\/S1415-47572014000200009","volume":"37","author":"P Ashton-Prolla","year":"2014","unstructured":"Ashton-Prolla P, Vargas FR (2014) Prevalence and impact of founder mutations in hereditary breast cancer in Latin America. Genetics and Molecular Biology 37:234\u2013240","journal-title":"Genetics and Molecular Biology"},{"key":"5378_CR37","first-page":"90","volume":"157","author":"A Puchmajerova","year":"2018","unstructured":"Puchmajerova A, Tornikidis J, Mrna L, Havlovicova M, Vlckova M et al (2018) Heredit\u00e1rn\u00ed formy karcinomu prsu: genetick\u00e1 etiologie a sou\u010dasn\u00e9 mo\u017enosti prevence a chirurgick\u00e9 l\u00e9\u010dby. \u010casopis l\u00e9ka\u0159\u016f \u010desk\u00fdch 157:90\u201395","journal-title":"\u010casopis l\u00e9ka\u0159\u016f \u010desk\u00fdch"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-020-05378-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:28:12Z","timestamp":1615854492000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-020-05378-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["5378"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05378-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"21 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study is approved by Ethic committee of Nov\u00fd Ji\u010d\u00edn Hospital in the Czech Republic.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}